ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
9.34
+0.10 (1.08%)
At close: Dec 16, 2025, 4:00 PM EST
9.10
-0.24 (-2.57%)
After-hours: Dec 16, 2025, 7:57 PM EST
ProMIS Neurosciences Market Cap
ProMIS Neurosciences has a market cap or net worth of $20.1 million as of December 16, 2025. Its market cap has decreased by -34.57% in one year.
Market Cap
20.10M
Enterprise Value
4.67M
1-Year Change
-34.57%
Ranking
Category
Stock Price
$9.34
Market Cap Chart
Since April 16, 2012, ProMIS Neurosciences's market cap has decreased from $21.82M to $20.10M, a decrease of -7.87%. That is a compound annual growth rate of -0.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 19.89M | -35.81% |
| Dec 31, 2024 | 30.98M | 42.66% |
| Dec 29, 2023 | 21.72M | -41.67% |
| Dec 30, 2022 | 37.23M | -24.28% |
| Dec 31, 2021 | 49.17M | 104.73% |
| Dec 31, 2020 | 24.02M | -34.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 943.99B |
| Johnson & Johnson | 504.27B |
| AbbVie | 395.31B |
| UnitedHealth Group | 302.73B |
| AstraZeneca | 281.22B |
| Novartis AG | 259.57B |
| Merck & Co. | 243.91B |
| Abbott Laboratories | 220.59B |